Massachusetts · Bill 689 · 193rd General Court

An Act relative to patient access to biomarker testing to provide appropriate therapy

  1. Introduced Feb 16, 2023
  2. In committee Feb 16, 2023
  3. Died  
  4. Passed the House  
  5. To the governor  
  6. Became law  

What it does

The legislature's own summary of the bill, or its official long title.

By Ms. Moran, a petition (accompanied by bill, Senate, No. 689) of Susan L. Moran, Jack Patrick Lewis, Michael O. Moore, William J. Driscoll, Jr. and other members of the General Court for legislation relative to patient access to biomarker testing to provide appropriate therapy. Financial Services.

Every action

7 steps, oldest first, as the legislature records them.

  1. CommitteeReferred to the committee on Financial Services · Joint Committee on Financial Services
  2. HouseHouse concurred
  3. CommitteeHearing rescheduled to 05/02/2023 from 10:00 AM-01:00 PM in Gardner Auditorium · Joint Committee on Financial Services
  4. HouseReporting date extended to Friday May 17, 2024, pending concurrence
  5. SenateSenate concurred
  6. CommitteeBill reported favorably by committee and referred to the committee on Health Care Financing · Joint Committee on Health Care Financing
  7. HouseAccompanied H1074

Roll calls

No recorded votes on this bill yet.

Sponsors

The member who introduced it, joined by 29 cosponsors: 23 Democrats, 6 Republicans.

  • SL Susan L. MoranD Primary sponsor · District Plymouth and Barnstable
All 29 cosponsors

From Massachusetts's official records (malegislature.gov/api), checked Nov 14, 2026. Text links go to the official versions; LegiList does not copy bill text.